In an asymptomatic patient with microscopic urine analysis showing 0–2 red blood cells per high-power field, what is the next step in management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of 0-2 RBC/HPF in Asymptomatic Patient

In an asymptomatic patient with 0-2 red blood cells per high-power field on microscopic urinalysis, repeat the urinalysis on two additional properly collected specimens before proceeding with any urologic evaluation. This finding does not meet the diagnostic threshold for microscopic hematuria, which requires ≥3 RBC/HPF. 1

Diagnostic Threshold and Confirmation

The American Urological Association defines clinically significant microscopic hematuria as ≥3 RBC/HPF on microscopic evaluation of urinary sediment from two of three properly collected urinalysis specimens. 1 Your patient's finding of 0-2 RBC/HPF falls below this threshold and does not constitute true microscopic hematuria requiring urologic workup. 1

Key Action Steps:

  • Obtain two additional properly collected, clean-catch, midstream urine specimens for microscopic examination to confirm whether persistent hematuria ≥3 RBC/HPF exists. 1

  • If dipstick testing was used initially, confirm with microscopic examination of urinary sediment, as dipstick has limited specificity (65-99%) and frequently produces false-positives. 1, 2

  • Ensure proper specimen collection to avoid contamination from menstruation, vaginal sources in women, or recent vigorous exercise, sexual activity, or trauma. 1

Risk Stratification Before Deferring Evaluation

Before deciding to defer evaluation in patients with 1-2 RBC/HPF, assess for high-risk factors that may warrant earlier or more aggressive evaluation even with borderline findings. 1

High-Risk Factors Requiring Consideration:

  • Age >40 years (or >35 years per ACR guidelines) 1
  • Smoking history 1
  • Occupational exposure to chemicals or dyes (benzenes, aromatic amines) 1
  • History of gross hematuria 1
  • History of urologic disorder or disease 1
  • Irritative voiding symptoms 1
  • Analgesic abuse 1
  • History of pelvic irradiation 1
  • Chronic urinary tract infection 1

High-risk patients should be considered for full urologic evaluation after one properly performed urinalysis documenting ≥3 RBC/HPF, rather than waiting for confirmation on multiple specimens. 1

If Hematuria Remains <3 RBC/HPF

If repeat urinalyses continue to show <3 RBC/HPF and the patient is low-risk, no urologic evaluation is warranted. 1 Studies demonstrate that patients with 1-2 RBC/HPF without risk factors have extremely low rates of significant pathology. 3, 4

Important Caveats:

  • Rule out urinary tract infection first if pyuria or bacteriuria is present, as infection can cause transient hematuria. Treat appropriately and repeat urinalysis 6 weeks after treatment. 1

  • Exclude benign transient causes: Repeat urinalysis 48 hours after cessation of menstruation, vigorous exercise, sexual activity, or recent urologic procedures if these are suspected causes. 1

  • Screen for renal parenchymal disease by checking for proteinuria, red cell casts, dysmorphic RBCs, or elevated creatinine. If present, concurrent nephrology referral is indicated regardless of RBC count. 1

Cost and Quality Considerations

Inappropriate referral and evaluation of patients without confirmed microscopic hematuria (≥3 RBC/HPF) represents a significant healthcare burden. One study found that 76% of patients referred for "asymptomatic hematuria" did not have confirmed microscopic hematuria by guideline definitions, resulting in unnecessary costs exceeding $44,000 in Medicare reimbursements for just 69 patients. 2

Another study demonstrated that changing laboratory reporting to differentiate 1-2 RBC/HPF from 3-5 RBC/HPF could save an estimated $745,000 annually by preventing unnecessary investigations. 4

Clinical Bottom Line

For your patient with 0-2 RBC/HPF:

  1. Repeat urinalysis twice more with properly collected specimens 1
  2. If all three specimens show <3 RBC/HPF and the patient is low-risk, reassure and discharge from urologic concern 1, 4
  3. If any specimen shows ≥3 RBC/HPF, proceed with full hematuria evaluation per AUA guidelines 1
  4. If high-risk factors are present, consider full evaluation even with a single specimen showing ≥3 RBC/HPF 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Quality and cost assessment of Canadian Urological Association microscopic hematuria guidelines in clinical practice: Turning urine into gold.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.